| Investigation of lifetime alcohol drinking with cancer and mortality risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Erikka Cronin |
Erikka Loftfield Cronin |
PLCO |
Jun 2, 2025 |
PLCO-1932 |
| Medical Image Analysis and Causal Machine Learning |
Xujiong Ye |
University of Exeter |
PLCO |
Apr 23, 2025 |
PLCOI-1872 |
| Metabolomic Profiles of Diabetes-Risk Reduction Diet and Cancer Risk |
Maryam Farvid |
George Mason University |
PLCO |
Apr 23, 2025 |
PLCO-1863 |
| Metabolomic Profiles of Ultra-Processed vs. Unprocessed/Minimally Processed Foods in Cancer Risk Prediction: Examining Effect Modification by Smoking- and Obesity-Related Metabolites |
Maryam Farvid |
George Mason University |
PLCO |
Apr 23, 2025 |
PLCO-1882 |
| Development of a Multimodal AI Model for Predicting Future Lung Cancer Risk from Chest X-rays in Asymptomatic Individuals |
Hyunsuk Yoo |
Evom AI |
PLCO |
Apr 23, 2025 |
PLCOI-1892 |
| Pan-Cancer Risks and Mortality: Multidimensional Associations with Lifestyle, Sociodemographics, and Diet/Nutrition Using the PLCO Database |
Yuxiang Luo |
Erasmus University Medical Center |
PLCO |
Apr 21, 2025 |
PLCO-1886 |
| Blood Analysis-Driven Machine Learning for Ovarian Cancer Detection |
Ivan Shtepliuk |
Linköping University |
PLCO |
Apr 21, 2025 |
PLCO-1879 |
| Pilot Study for serum and plasma samples |
Camargo Costanza |
NIH |
PLCO |
Apr 3, 2025 |
2025-9010 |
| Genetic and environmental risk factors for multiple primary cancers |
Sonja Berndt |
National Cancer Institute |
PLCO |
Apr 2, 2025 |
PLCO-1873 |
| Leveraging Self-Supervised Vision Transformers for Non-Invasive Lung Cancer Biomarker Prediction from Full-Resolution Chest X-Rays |
Tianyu Han |
University of Pennsylvania |
PLCO |
Mar 25, 2025 |
PLCOI-1862 |
| Exploratory assessment of datasets |
Amanda Skarlupka |
National Cancer Institute - Division of Cancer Prevention |
PLCO |
Mar 21, 2025 |
PLCO-1865 |
| Genome-Wide Association Study of Acute Myeloid Leukemia in Genomic Studies in Blood and Marrow Transplantation |
Filip Pirsl |
National Cancer Institute |
PLCO |
Mar 18, 2025 |
PLCO-1861 |
| A European “shield” against colorectal cancer (ONCOSCREEN) |
Amal Elgammal |
Amal Elgammal |
PLCO |
Mar 18, 2025 |
PLCO-1845 |
| Development and Validation of a Machine Learning Model for Predicting Sentinel Lymph Node Metastasis in Melanoma Patients |
Diego Mendez |
Hospital El Pino |
PLCO |
Mar 18, 2025 |
PLCO-1855 |
| Sample selection for multiple myeloma proteomics study |
Eleanor Watts |
National Cancer Institute |
PLCO |
Mar 18, 2025 |
PLCO-1856 |
| Enhancing Decision-Making with Real-World Evidence: Population Adjustments, Outcome Prediction, and Cost-Effectiveness Analytics |
Reut Lanyado |
Reut Lanyado |
PLCO |
Mar 12, 2025 |
PLCO-1849 |
| Machine learning research for endometrial cancer |
Mario Lovric |
Institute for Anthropological Research |
PLCO |
Mar 12, 2025 |
PLCO-1853 |
| Exploration of Explainable AI Models using Machine Learning for Prostate Cancer Diagnosis |
Omoye Esangbedo |
University of Derby |
PLCO |
Mar 12, 2025 |
PLCO-1843 |
| Considering explainability and privacy when developing machine learning models to predict early risk of cancer |
Christopher Duckworth |
University of Southampton |
PLCO |
Feb 20, 2025 |
PLCO-1837 |
| Validation of blood metabolites related to diet and cardiovascular mortality |
Lei Wang |
Vanderbilt University Medical Center |
PLCO |
Feb 19, 2025 |
PLCO-1820 |
